Overview of syndromes and disorders associated with developmental disability
There is an increasing number of identified rare aetiologies associated with developmental disability that a general practitioner (GP) may need to manage. In addition to specialist multidisciplinary input, the GP has an important role in the care of the person, providing regular health surveillance and support; see Role of the general practitioner in the care of a person with developmental disability.
For advice on assessment of a person with developmental delay or disability, see here.
Once an aetiology for a developmental disability has been established, it can be useful to include a summary of the specific risk factors associated with the aetiology as a reminder in the patient health record. These factors should be reviewed as clinically indicated and as part of the person’s annual comprehensive health assessment. Many aetiologies for rare developmental disabilities will have established behaviour phenotypes, which are important determinants for management and support of patients. People with developmental disability and their family or carers may have researched the condition and can often contribute to clinical information. Information specific to the aetiology can be helpful to include when drawing up a National Disability Insurance Scheme (NDIS) support plan.
[NB1]
Better Health Channel Genetic conditions, State Government of Victoria
GeneReviews, National Center for Biotechnology Information (NCBI) (US)
Genomics in general practice , Royal Australian College of General Practitioners (RACGP)
Mayo Clinic (US), diseases and conditions
MedlinePlus Genetics US National Library of Medicine
National Center for Advancing Translational Sciences, Genetic and Rare Diseases Information Center (GARD) (US)
National Organization for Rare Disorders (NORD) (US)
Online Mendelian Inheritance in Man (OMIM) (US), a catalogue of human genes and genetic disorders
Society for the Study of Behavioural Phenotypes: syndrome sheets
Unique Understanding rare chromosome and gene disorder guides
Recommended practice during a consultation with a person with developmental disability is outlined in General practice and emergency presentation of a person with developmental disability.
For advice on the general health care of people with developmental disability at various life stages, see children, adolescents, adults or people who are ageing.
Fetal alcohol spectrum disorder | |
frequency |
estimated prevalence 1 in 4000 |
genetic cause | |
characteristics | |
health considerations |
preventive health and screening for people with 22q11.2 deletion syndrome |
support organisations | |
Angelman syndrome | |
frequency |
estimated 1 in 12 000 to 20 000 people |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
frequency |
around 1% of the population; estimated 1 in 70 to 150 people |
genetic cause | |
characteristics | |
health considerations |
preventive health and screening for people with autism spectrum disorder |
support organisations | |
frequency |
about 35 500 people in Australia; 1.4 in 1000 live births in Australia |
genetic cause |
not applicable; causes of cerebral palsy |
characteristics | |
health considerations |
preventive health and screening for people with cerebral palsy |
support organisations |
Cerebral Palsy Australia; State-based support organisations are listed in Resources for information about syndromes and disorders associated with developmental disability
|
CHARGE syndrome | |
frequency |
approximately 1 in 8500 to 10 000 newborns |
genetic cause | |
characteristics | |
health considerations | |
support organisations |
CHARGE Syndrome Association of Australasia; The CHARGE Syndrome Foundation (US) |
Coffin–Lowry syndrome | |
frequency |
estimated 1 in 40 000 to 50 000 people |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Cornelia de Lange syndrome | |
frequency |
exact incidence unknown; likely 1 in 10 000 to 30 000 newborns |
genetic cause | |
characteristics | |
health considerations | |
support organisations |
Cornelia de Lange Syndrome (CdLS) Association (Australasia) Inc |
Cri du chat syndrome | |
frequency |
estimated 1 in 20 000 to 50 000 newborns |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
frequency |
approximately 1 in 800 newborns |
genetic cause | |
characteristics | |
health considerations |
preventive health and screening for people with Down syndrome |
support organisations |
Down Syndrome Australia, includes links to state-based support organisations |
frequency |
no reliable national prevalence data for the general Australian population |
genetic cause |
not applicable |
characteristics | |
health considerations |
preventive health and screening for people with fetal alcohol spectrum disorder |
support organisations |
National Organisation for Fetal Alcohol Spectrum Disorder (NOFASD) Australia |
frequency |
approximately 1 in 3600 to 4000 people in the general population |
genetic cause | |
characteristics | |
health considerations |
preventive health and screening for people with fragile X syndrome |
support organisations |
Fragile X Alliance Inc; The Fragile X Association of Australia; National Fragile X Foundation (US) |
Lesch Nyhan syndrome | |
frequency |
approximately 1 in 380 000 individuals |
genetic cause | |
characteristics | |
health considerations | |
support organisations |
included in Genetic Alliance Australia |
frequency |
estimated 1 in 3000 people |
genetic cause | |
characteristics | |
health considerations |
preventive health and screening for people with neurofibromatosis type 1 |
support organisations |
Children’s Tumour Foundation; Children’s Tumor Foundation (US) |
Noonan syndrome | |
frequency |
approximately 1 in 1000 to 2500 people |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Phelan–McDermid syndrome (22q13.3 deletion syndrome) | |
frequency |
more than 2200 people diagnosed worldwide |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Prader–Willi syndrome | |
frequency |
estimated 1 in 10 000 to 30 000 people |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Rett syndrome | |
frequency |
estimated 1 in 9000 to 10 000 females |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Smith–Magenis syndrome | |
frequency |
at least 1 in 25 000 individuals; possibly 1 in 15 000 individuals |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Sotos syndrome | |
frequency |
reported to occur in 1 in 10 000 to 14 000 newborns |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Tuberous sclerosis complex | |
frequency |
about 1 in 6000 people |
genetic cause | |
characteristics | |
health considerations | |
support organisations | |
Williams syndrome | |
frequency |
estimated 1 in 7500 to 10 000 people |
genetic cause | |
characteristics | |
health considerations | |
support organisations |
Williams Syndrome Australia; Williams Syndrome Foundation (UK) |
Note:
NB1: As well as links to information in these guidelines, links are provided to information in MedlinePlus (National Institutes of Health [NIH], US National Library of Medicine), and in GeneReviews and StatPearls (National Center for Biotechnology Information [NCBI], US National Library of Medicine). NB2: Resources for information about syndromes and disorders associated with developmental disability lists some other sources of information about syndromes and disorders associated with developmental disability.
|